Review seeks public views on baby sex selection [UK]
By The Guardian,
The Guardian
| 08. 16. 2005
The option for parents to select the sex of their next baby to balance their family is raised in a public consultation document published today.
The government said that its review of the Human Fertilisation and Embryology Act of 1990 will seek views from the public on sex selection for non-medical purposes.
The review will ask whether the practice should be banned - as it is currently - or be allowed for family balancing reasons.
Sex selection is allowed by the Human Fertilisation and Embryology Authority (HFEA) in order to avoid babies being born with disorders such as haemophilia.
But its use for family balancing was opposed by the fertility watchdog after a public consultation.
Now the government has raised the issue again in its wide-ranging consultation on fertility legislation, which has not been updated for 15 years.
The review will also consider, if sex selection was made more widely available, how many children of one gender should a couple already have before they are allowed to use screening techniques to try for a child of another gender.
Sex selection...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...
